Table 1B.
Co.ef | Std.Err. | P Value | Haz.ratio(95% CI) | |
---|---|---|---|---|
Combined pathway enrichment clustering | -0.255 | 0.134 | 0.048 | 0.775 (0.596-1.009) |
Molecular subtype | -0.319 | 0.157 | 0.042 | 0.727 (0.535-0.988) |
G-CIMP | -1.194 | 0.244 | <0.001 | 0.303 (0.188-0.489) |
Treatment modality | -0.783 | 0.211 | <0.001 | 0.457 (0.302-0.692) |
Age | 0.435 | 0.124 | <0.001 | 1.545 (1.211-1.972) |
No. of subjects = 368; No. of event = 328; No. of censored = 40. Log likelihood = 3226.034. Method: Backward likewise
Combined pathway enrichment clustering: 0=Cluster A,B &C group. 1= Cluster D & E group.
Molecular subtype: 0= Non-proneural subtype. 1= Proneural subtype.
G-CIMP: 0=Non-C-CIMP, 1=G-CIMP
Treatment modality: 0= Without chemotherapy or radiotherapy, 1= Chemotherapy with/or radiotherapy.
Age: 0=Age<65 years, 1= Age>65 years.
KPS:0= KPS<70, 1=KPS>=70.
Gender: 0=Female, 1= Male.